David Cameron Reveals Prostate Cancer Diagnosis, Advocates

Published: 24 November 2025. The English Chronicle Desk. The English Chronicle Online.

Former UK Prime Minister David Cameron has revealed that he was treated for prostate cancer and is now publicly calling for a targeted screening programme to help detect the disease earlier. Cameron, aged 59, disclosed that a routine prostate-specific antigen (PSA) test revealed elevated levels of a protein associated with prostate cancer, which led him to undergo a biopsy confirming the diagnosis.

Cameron described receiving the diagnosis as a profoundly unsettling experience, explaining that the moment the doctor uttered the words “you have prostate cancer,” he immediately felt the gravity of the situation. “You always hope for the best. You have a high PSA score – that’s probably nothing. You have an MRI scan with a few black marks on it. You think, ‘Ah, that’s probably OK.’ But when the biopsy comes back, and it says you have got prostate cancer, you always dread hearing those words,” Cameron told the Times.

The former Conservative party leader credited his wife, Samantha Cameron, for urging him to take the test, following a radio interview in which Soho House founder Nick Jones discussed his own prostate cancer diagnosis. Encouraged by this example, Cameron underwent the necessary tests, ultimately revealing that he had early-stage prostate cancer. He received focal therapy, a treatment method that targets cancer cells with electrical pulses while sparing surrounding tissue, and reported a successful recovery from the procedure.

In his public disclosure, Cameron emphasised the importance of early detection and urged the government to introduce a targeted prostate cancer screening programme for men at higher risk. He explained that men generally tend to postpone medical appointments, often avoiding discussions about their own health, which can result in cancers being detected at later stages. “I want to, as it were, come out. I want to add my name to the long list of people calling for a targeted screening programme. We need to make it easier for men to be tested and to act on their health concerns,” Cameron stated.

Prostate cancer is the most common cancer in men in the UK, with approximately 55,000 new cases diagnosed each year. Despite its prevalence, there is currently no national screening programme due to concerns over the accuracy of PSA tests and the risk of overdiagnosis. However, Cameron’s disclosure comes at a crucial moment, coinciding with the launch of the Transform Project, a major trial investigating the most effective prostate cancer screening methods. The study aims to compare these newer techniques with existing NHS diagnostic procedures, which currently rely on PSA testing and biopsies, with the goal of improving early detection and saving lives.

The Transform Project is funded in partnership between the NHS, the National Institute for Health and Care Research, which has committed £16 million, and the charity Prostate Cancer UK, which is contributing the remaining funding. Cameron highlighted that his experience demonstrates the life-saving potential of early testing and screening, particularly for men who may otherwise remain unaware of the disease until it reaches an advanced stage.

Chiara De Biase, director of health services, equity, and improvement at Prostate Cancer UK, welcomed Cameron’s announcement. “We’re glad to hear that David Cameron found his prostate cancer at an early stage and had successful treatment. His willingness to share his story is helping raise vital awareness of this disease, which is completely curable if found early. Men’s lives should not be left to chance,” she said. De Biase emphasised that in the UK alone, 12,000 men die each year from prostate cancer, making early diagnosis essential.

Cameron reflected on the emotional and psychological impact of being diagnosed with a serious illness, noting that the initial anxiety was quickly replaced by determination to take decisive action. “When the doctor first told me, you think, ‘Oh no, he’s going to say it. He’s going to say it. Oh God, he said it.’ But immediately, you understand the importance of moving quickly, listening to medical advice, and taking every opportunity to manage the disease effectively,” he explained.

Cameron’s call for targeted screening is also driven by concern for men at higher risk, including those from certain ethnic backgrounds and working-class communities. Evidence suggests that black men in the UK face a higher incidence of aggressive prostate cancer, while men from lower-income areas often experience delayed diagnosis due to fewer interactions with healthcare services. Cameron stressed that a more systematic and accessible screening programme could save thousands of lives by ensuring earlier detection and intervention.

The former prime minister resigned as the leader of the Conservative Party and MP for Witney in 2016, following the Brexit referendum. In 2023, he was appointed as foreign secretary by Prime Minister Rishi Sunak and was granted a life peerage, taking his seat in the House of Lords. He noted that public figures discussing personal health challenges can play an important role in encouraging wider awareness and responsible healthcare engagement among men, a demographic historically reluctant to seek preventative care.

The announcement also coincides with recent developments in the NHS’s approach to prostate cancer detection. The UK National Screening Committee is currently reviewing the latest evidence on screening and may announce decisions in the near future regarding the introduction of routine testing for at-risk men. Cameron believes that sharing his story publicly can create momentum for this policy change, potentially saving lives for men who might otherwise remain undiagnosed until it is too late.

Experts have praised Cameron for using his platform to raise awareness. Dr. Emma Curtis, a leading urologist, said, “Hearing public figures openly discuss prostate cancer can dramatically improve early diagnosis rates. Men are less likely to discuss their health issues, and campaigns like this can encourage more people to take action.”

Cameron concluded by reiterating his belief in the critical importance of screening and early intervention. He urged men to be proactive about their health, stressing that detection at an early stage greatly increases the chances of successful treatment. His advocacy aligns with broader public health campaigns seeking to reduce preventable deaths and ensure men are informed about the risks and symptoms of prostate cancer.

The Transform Project, NHS initiatives, and Cameron’s personal example collectively highlight the urgent need for more systematic approaches to prostate cancer detection. As discussions continue in the UK regarding the implementation of targeted screening, Cameron’s disclosure may serve as a pivotal moment in reshaping national attitudes toward men’s health and preventative care.